July 16, 2020

​

Organic electrochemistry has the potential to have significant technical and economic benefits for the synthesis of APIs.  Electrochemical synthesis uses electrons as a reagent, which can enable more efficient transformations than the use of traditional chemical reagents, and can result in safer, more cost effective processes that have less waste generation, use fewer chemical raw materials, and result in a more streamlined chemical synthesis.
 
Electrochemistry is used widely in the chemical industry. However, existing manufacturing equipment generally is not suitable for the types of reactions of interest for the pharmaceutical industry. This lack of equipment availability is a major hurdle incorporating the technology into pharmaceutical processes. For electrochemistry to gain wide applicability in the pharmaceutical industry, it requires equipment infrastructure that is safe and robust to a range of reaction types and conditions, at a scale relevant to API manufacturing. For this reason, the ETC is interested in partnering to design and build lab and manufacturing scale electrochemical reactors that meet the safety, robustness and productivity needs of the pharmaceutical industry.

​

Download the Request for Information and submit your response.

​

RFP ISSUED JULY 16, 2020

QUESTIONS on RFP DUE AUGUST 10, 2020 - Latest Q&A (Updated Aug 11, 2020)

RFP RESPONSES DUE AUGUST 31, 2020

​

​